Resistin promotes the growth and aggressiveness of breast cancer cells through STAT3 activation, indicating a potential role of resistin, IL-6 and STAT3 in breast cancer racial disparity in AA women [45]. This evidence concerns the gene STAT3 and breast carcinoma.